Lehto VP - Search Results

1

Direct mitigation of secondary organic aerosol particulate pollutants by multiphase photocatalysis.

Hao L, Li Z, Yli-Juuti T, Ylisirniö A, Pullinen I, Miettinen P, Xu W, Lehto VP, Worsnop DR, Virtanen A. Hao L, et al. Among authors: lehto vp. Sci Total Environ. 2024 May 1;923:171323. doi: 10.1016/j.scitotenv.2024.171323. Epub 2024 Mar 2. Sci Total Environ. 2024. PMID: 38438031 Free article.

2

Surface chemistry, reactivity, and pore structure of porous silicon oxidized by various methods.

Riikonen J, Salomäki M, van Wonderen J, Kemell M, Xu W, Korhonen O, Ritala M, MacMillan F, Salonen J, Lehto VP. Riikonen J, et al. Among authors: lehto vp. Langmuir. 2012 Jul 17;28(28):10573-83. doi: 10.1021/la301642w. Epub 2012 Jul 2. Langmuir. 2012. PMID: 22671967

3

Mesoporous systems for poorly soluble drugs.

Xu W, Riikonen J, Lehto VP. Xu W, et al. Among authors: lehto vp. Int J Pharm. 2013 Aug 30;453(1):181-97. doi: 10.1016/j.ijpharm.2012.09.008. Epub 2012 Sep 8. Int J Pharm. 2013. PMID: 22990124 Review.

4

Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.

Huotari A, Xu W, Mönkäre J, Kovalainen M, Herzig KH, Lehto VP, Järvinen K. Huotari A, et al. Among authors: lehto vp. Int J Pharm. 2013 Sep 15;454(1):67-73. doi: 10.1016/j.ijpharm.2013.06.063. Epub 2013 Jul 5. Int J Pharm. 2013. PMID: 23834832

5

Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.

Rytkönen J, Arukuusk P, Xu W, Kurrikoff K, Langel U, Lehto VP, Närvänen A. Rytkönen J, et al. Among authors: lehto vp. Mol Pharm. 2014 Feb 3;11(2):382-90. doi: 10.1021/mp4002624. Epub 2013 Dec 30. Mol Pharm. 2014. PMID: 24341621

6

Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy.

Xu W, Thapa R, Liu D, Nissinen T, Granroth S, Närvänen A, Suvanto M, Santos HA, Lehto VP. Xu W, et al. Among authors: lehto vp. Mol Pharm. 2015 Nov 2;12(11):4038-47. doi: 10.1021/acs.molpharmaceut.5b00473. Epub 2015 Oct 5. Mol Pharm. 2015. PMID: 26390039

7

Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery.

Korhonen E, Rönkkö S, Hillebrand S, Riikonen J, Xu W, Järvinen K, Lehto VP, Kauppinen A. Korhonen E, et al. Among authors: lehto vp. Eur J Pharm Biopharm. 2016 Mar;100:1-8. doi: 10.1016/j.ejpb.2015.11.020. Epub 2015 Dec 11. Eur J Pharm Biopharm. 2016. PMID: 26686646

8

Chlorin e6 Functionalized Theranostic Multistage Nanovectors Transported by Stem Cells for Effective Photodynamic Therapy.

Näkki S, Martinez JO, Evangelopoulos M, Xu W, Lehto VP, Tasciotti E. Näkki S, et al. Among authors: lehto vp. ACS Appl Mater Interfaces. 2017 Jul 19;9(28):23441-23449. doi: 10.1021/acsami.7b05766. Epub 2017 Jul 5. ACS Appl Mater Interfaces. 2017. PMID: 28640590 Free PMC article.

9

Nano Air Seeds Trapped in Mesoporous Janus Nanoparticles Facilitate Cavitation and Enhance Ultrasound Imaging.

Tamarov K, Sviridov A, Xu W, Malo M, Andreev V, Timoshenko V, Lehto VP. Tamarov K, et al. Among authors: lehto vp. ACS Appl Mater Interfaces. 2017 Oct 11;9(40):35234-35243. doi: 10.1021/acsami.7b11007. Epub 2017 Sep 28. ACS Appl Mater Interfaces. 2017. PMID: 28921952

10

Dual Contrast CT Method Enables Diagnostics of Cartilage Injuries and Degeneration Using a Single CT Image.

Saukko AEA, Honkanen JTJ, Xu W, Väänänen SP, Jurvelin JS, Lehto VP, Töyräs J. Saukko AEA, et al. Among authors: lehto vp. Ann Biomed Eng. 2017 Dec;45(12):2857-2866. doi: 10.1007/s10439-017-1916-3. Epub 2017 Sep 18. Ann Biomed Eng. 2017. PMID: 28924827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters